Richmond Pharmacology is excited to attend the 2024 American HeartAssociation (AHA) Scientific Sessions in Philadelphia. This premier event incardiovascular science will bring together global leaders to present anddiscuss the latest innovations in cardiovascular research, prevention, andtreatment. The sessions will cover a wide range of topics, including basic,clinical, and population science.

To connect with our team during the event, please reach out to arrange ameeting.

For more information, visit the AHA Scientific Sessions 2024 website.

Latest news

Red4Research Blog – Alan’s Story

June 24, 2025
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Read more

Richmond Appoints Lisa Campbell as Director of Regulatory Strategy

April 23, 2025
Richmond Pharmacology is pleased to announce the appointment of Lisa Campbell as Director of Regulatory Strategy
Read more

Events

HFA 2025

17–20 May 2025
Richmond Pharmacology will participate in HFA 2025 in Belgrade from 17–20 May, focusing on heart failure research, clinical trials, and scientific collaboration.
View event